SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 7, 2008, Pages 769-776

  Cheng, Lei ^a   Zhou, Liang ^a   Tao, Lei ^a   Zhang, Ming ^a   Cui, Jiefeng ^a   Li, Yan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Decision tree; Laryngeal squamous cell carcinoma; Metastasis; Proteome biomarkers; Surface enhanced laser desorption ionization mass spectrometry

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CATION EXCHANGE; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; INFORMED CONSENT; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SQUAMOUS CELL CARCINOMA; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION PROCESS;

CARCINOMA, SQUAMOUS CELL; DECISION TREES; DISEASE PROGRESSION; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 43449103359     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0344-4     Document Type: Article

References (26)

1. Adam BL, Vlahou A, Semmes OJ, Wright GL Jr (2001) Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 1:1264-1270
2. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr (2002) Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62:3609-3614
3. Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, Wright GL Jr (2002) Normal, benign, preneoplastic,and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 8:2541-2552
4. Diamandis EP (2003) Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 49(8):1272-1275
5. Gretzer MB, Chan DW, van Rootselaar CL, Rosenzweig JM, Dalrymple S, Mangold LA, Partin AW, Veltri RW (2004) Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF. Prostate 60(4):325-331
6. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48:1296-1304
7. Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C, Janeau JL, Bezeaud A, Delforge D, Cubizolles M, Laurendeau I, Bedossa P (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41:40-47
8. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-577
9. Poon TC, Yip TT, Chan AT, Yip C, Yip V, Mok TS, Lee CC, Leung TW, Ho SK, Johnson PJ (2003) Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 49:752-760
10. Sarno A, Bocciolini C, Deganello A, Coscarelli S, Gallo O (2004) Does unnecessary elective neck treatment affect the prognosis of N0 laryngeal cancer patients? Acta Otolaryngol 124(8):980-985
11. Schwegler EE, Cazares L, Steel LF, Adam BL, Johnson DA, Semmes OJ, Block TM, Marrero JA, Drake RR (2005) SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 41(3):634-642
12. Semmes OJ, Feng Z, Adam B, Banez LL, Bigbee WL, Campos D, Cazares LH et al (2005) Evaluation of SELDI-TOF-MS serum protein profiling for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 51(1):102-112
13. Shah JP, Karnell LH, Hoffman HT, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen A (1997) Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg 123(5):475-483
14. Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, Koong AC (2004) The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res 15 10(14):4806-48122
15. Srinivas PR, Srivastava S, Hanash S, Wright GL Jr (2001) Proteomics in early detection of cancer. Clin Chem 47:1901-1911
16. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, Nasim S, Wright GL Jr (2001) Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 58:149-501
17. Vlahou A, Schorge JO, Gregory BW, Coleman RL (2003a) Diagnosis of ovarian cancer using decision tree classification of mass spectral data. J Biomed Biotechnol 2003:308-314
18. Vlahou A, Laronga C, Wilson L, Gregory B, Fournier K, McGaughey D, Perry RR, Wright GL Jr, Semmes OJ (2003b) A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer 4:203-209
19. Von Eggeling F, Junker K, Fiedle W, Wollscheid V, Durst M, Claussen U, Ernst G (2001) Mass spectrometry meets chip technology: a new proteomic tool in cancer research? Electrophoresis 22:2898-2902
20. Wadsworth JT, Somers KD, Stack BC Jr, Cazares L, Malik G, Adam BL, Wright GL Jr, Semmes OJ (2004) Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 130(1):98-104
21. Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L (2002) Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 19(4):319-326
22. Xiao X, Liu D, Tang Y, Guo F, Xia L, Liu J, He D (2003) Development of proteomic patterns for detecting lung cancer. Dis Markers 19:33-39
23. Xiao X, Zhao X, Liu J, Guo F, Liu D, He D (2004) Discovery of laryngeal carcinoma by serum proteomic pattern analysis. Sci China C Life Sci 47(3):219-223
24. Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, Zhang WH, Peng CH, Zhang SD, Li HW, Chen GQ (2005) Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 68(1):79-86
25. Zhang YF, Wu DL, Guan M, Liu WW, Wu Z, Chen YM, Zhang WZ, Lu Y (2004) Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. Clin Biochem 37(9):772-779
26. Zhukov TA, Johanson RA, Cantor AB, Clark RA, Tockman MS (2003) Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 40:267-279